Clinical Trials
19 trialsNCT03677596 2023-11-22
A Study Of Two Inotuzumab Ozogamicin Doses in Relapsed/ Refractory Acute Lymphoblastic Leukemia Transplant Eligible Patients
Pfizer
Phase 4 Completed
NCT01191541 2021-08-10
Ara-C
ChineseAMS
Phase 4 Completed
NCT00980018 2021-07-01
MACS0999
Novartis
Phase 4 Completed
NCT01856803 2020-09-25
Anti-thymocyte Globulins for Graft-versus-host Disease Prophylaxis
Peking University People's Hospital
Phase 4 Completed
NCT04187755 2019-12-06
Cefepime vs Ceftazidime as Empirical Therapy for Neutropenic Fever
Indonesia University
Phase 4 Completed
NCT00003398 2019-10-17
Bone Marrow Transplantation in Treating Patients With Hematologic Cancer
University of Maryland, Baltimore
Phase 4 Completed
NCT02095951 2018-12-19
Preemptive Ethanol Lock Therapy in Pediatric Bloodstream Infection
Children's Hospital of Michigan
Phase 4 Completed
NCT01347996 2017-11-29
Maintenance Therapy With Ceplene® (Histamine) and IL-2 on Immune Response and MRD in Acute Myeloid Leukemia
Cytovia, Inc.
Phase 4 Completed
NCT00666978 2017-11-13
Health Education Counseling With or Without Bupropion in Helping African Americans Stop Smoking
University of Kansas Medical Center
Phase 4 Completed
NCT01061177 2017-02-24
'MACS1252
Novartis
Phase 4 Completed
NCT00786812 2017-02-23
MACS0439
Novartis
Phase 4 Completed
NCT00365508 2016-03-29
Counseling and Nicotine Replacement Therapy in Helping Adult Smokers Quit Smoking
Fox Chase Cancer Center
Phase 4 Completed
NCT01227577 2016-02-08
MACS1428
Novartis
Phase 4 Completed
NCT00362544 2015-07-09
PROPHYSOME: Pilot Study on Safety of a Weekly Administration of 10mg/kg of AmBisome® in Antifungal Prophylaxis Treatment of Allogeneic Stem-cell Transplantation and Acute Leukaemia
Gilead Sciences
Phase 4 Completed
NCT00808171 2014-07-29
Evaluation of the Analgesy With Emla and/or Nitrous Oxide in Pediatric Patients for Lumbar Puncture
Federal University of Minas Gerais
Phase 4 Completed
NCT00143312 2009-10-06
VOSIFI
Pfizer
Phase 4 Completed
NCT00415103 2009-09-18
AMENO-2
PETHEMA Foundation
Phase 4 Completed
NCT00304447 2009-07-29
Study Evaluating the Effect of Corticosteroids on Mylotarg® Infusion-Related Adverse Events in Patients With Leukemia
Wyeth is now a wholly owned subsidiary of Pfizer
Phase 4 Completed
NCT00230217 2009-03-30
Study of Rasburicase as Treatment or Prevention of Hyperuricemia Associated With Tumor Lysis Syndrome in Patients With Relapsed or Refractory Lymphoma, Leukemia, or Solid Tumor Malignancy
Sanofi
Phase 4 Completed